Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Asberg

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|February 16, 2005
Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipientsMonica Hermann, Anders Asberg, Hege Christensen, et al.
Transplantation|April 23, 2009
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipientsRune Amundsen, Anders Asberg, Ida Robertsen, et al.
Therapeutic Drug Monitoring|March 11, 2010
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot studyAnders Asberg, Pål Falck, Liv H Undset, et al.
Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathyMonica Hermann, Martin P Bogsrud, Espen Molden, et al.
Surgical Endoscopy|December 19, 2012
Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatinGunn Signe Jakobsen, Ine Blankenberg Skottheim, Rune Sandbu, et al.
Therapeutic Drug Monitoring|January 3, 2012
The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitusFatemeh Akhlaghi, Miroslav Dostalek, Pål Falck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 25, 2007
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipientsPål Falck, Nils Tore Vethe, Anders Asberg, et al.
Transplantation|February 1, 2013
Endothelial dysfunction is associated with graft loss in renal transplant recipientsDag Olav Dahle, Karsten Midtvedt, Anders Hartmann, et al.
Transplantation|June 21, 2011
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipientsHans-Arne Myhre, Dagny Haug Dorenberg, Knut Ivan Kristiansen, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|February 16, 2005
Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipientsMonica Hermann, Anders Asberg, Hege Christensen, et al.
Transplantation|April 23, 2009
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipientsRune Amundsen, Anders Asberg, Ida Robertsen, et al.
Therapeutic Drug Monitoring|March 11, 2010
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot studyAnders Asberg, Pål Falck, Liv H Undset, et al.
Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathyMonica Hermann, Martin P Bogsrud, Espen Molden, et al.
Surgical Endoscopy|December 19, 2012
Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatinGunn Signe Jakobsen, Ine Blankenberg Skottheim, Rune Sandbu, et al.
Therapeutic Drug Monitoring|January 3, 2012
The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitusFatemeh Akhlaghi, Miroslav Dostalek, Pål Falck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 25, 2007
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipientsPål Falck, Nils Tore Vethe, Anders Asberg, et al.
Transplantation|February 1, 2013
Endothelial dysfunction is associated with graft loss in renal transplant recipientsDag Olav Dahle, Karsten Midtvedt, Anders Hartmann, et al.
Transplantation|June 21, 2011
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipientsHans-Arne Myhre, Dagny Haug Dorenberg, Knut Ivan Kristiansen, et al.
Pageof 6